- Home
- NRSN vs FTHM Comparison
NRSN vs FTHM Comparison
Compare NRSN & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- FTHM
- Stock Information
- Founded
- NRSN 2017
- FTHM 2010
- Country
- NRSN Israel
- FTHM United States
- Employees
- NRSN N/A
- FTHM N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- FTHM Real Estate
- Sector
- NRSN Health Care
- FTHM Finance
- Exchange
- NRSN Nasdaq
- FTHM Nasdaq
- Market Cap
- NRSN 26.0M
- FTHM 27.1M
- IPO Year
- NRSN 2021
- FTHM 2020
- Fundamental
- Price
- NRSN $0.91
- FTHM $0.78
- Analyst Decision
- NRSN Hold
- FTHM Strong Buy
- Analyst Count
- NRSN 1
- FTHM 4
- Target Price
- NRSN N/A
- FTHM $4.25
- AVG Volume (30 Days)
- NRSN 172.3K
- FTHM 87.0K
- Earning Date
- NRSN 04-08-2025
- FTHM 03-12-2025
- Dividend Yield
- NRSN N/A
- FTHM N/A
- EPS Growth
- NRSN N/A
- FTHM N/A
- EPS
- NRSN N/A
- FTHM N/A
- Revenue
- NRSN N/A
- FTHM $335,184,000.00
- Revenue This Year
- NRSN N/A
- FTHM $26.16
- Revenue Next Year
- NRSN N/A
- FTHM $23.48
- P/E Ratio
- NRSN N/A
- FTHM N/A
- Revenue Growth
- NRSN N/A
- FTHM N/A
- 52 Week Low
- NRSN $0.51
- FTHM $0.70
- 52 Week High
- NRSN $2.25
- FTHM $3.37
- Technical
- Relative Strength Index (RSI)
- NRSN 38.31
- FTHM 31.89
- Support Level
- NRSN $1.00
- FTHM $0.70
- Resistance Level
- NRSN $1.13
- FTHM $0.99
- Average True Range (ATR)
- NRSN 0.08
- FTHM 0.08
- MACD
- NRSN -0.02
- FTHM 0.01
- Stochastic Oscillator
- NRSN 28.23
- FTHM 17.65
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title.